Rituxan (rituximab) - Roche
Two Shots, One Kidney: A Case of Primary Membranous Nephropathy After Influenza and COVID-19 Vaccination (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #PUB144; "Given preserved kidney function and consideration of relapse risk, calcineurin inhibitors were deferred, and rituximab was administered for persistent nephrotic syndrome...Additionally, this case raises awareness of vaccination as a potential trigger for MN, while acknowledging that causality cannot be established. Recognition of these patterns is important to avoid premature changes in management and to guide appropriate longitudinal monitoring." 
Clinical • Cardiovascular • Glomerulonephritis • Hypertension • Immunology • Infectious Disease • Influenza • Nephrology • Novel Coronavirus Disease • Renal Disease • Respiratory Diseases
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4554246
 
Blessing U. Osondu
 
Oct 2, 2026
 
Prev Next